Elevated Gamma-GT in Neonates with Normal Direct Bilirubin

Diagnostic Evaluation

The American Academy of Pediatrics recommends a full fractionation of bilirubin to confirm that direct bilirubin is normal (if total bilirubin ≤5 mg/dL, direct bilirubin >1.0 mg/dL is considered abnormal) 1, 2, 3, 4
A complete liver function test, including ALT, AST, alkaline phosphatase, albumin, and PT/INR, should be performed to evaluate the liver function 5

Ultrasonography of the hepatobiliary system should be performed to rule out structural biliary obstruction 5, 6
If Progressive Familial Intrahepatic Cholestasis (PFIC) type 3 is suspected, a liver biopsy and genetic testing should be considered 5, 6

Serial measurements of GGT and direct bilirubin should be performed every 1-2 weeks to detect the development of cholestasis 5, 6
If GGT continues to rise or direct bilirubin starts to increase, a comprehensive evaluation for biliary atresia or other hepatobiliary diseases should be performed promptly 5, 6
Clinical signs such as acholic stools, dark urine, and hepatomegaly should be monitored, as they may indicate the development of cholestasis 5, 6

Any neonate with conjugated bilirubin >25 μmol/L (>1.0 mg/dL when total bilirubin ≤5 mg/dL) requires urgent evaluation for biliary atresia or other cholestatic diseases 6
Persistent jaundice at or after 3 weeks with conjugated hyperbilirubinemia defines pathological neonatal cholestasis that requires immediate intervention 6
The Kasai portoenterostomy procedure should be performed ideally before 60 days of age to maximize success and prevent the need for liver transplantation 6

The American Academy of Pediatrics recommends obtaining complete bilirubin fractionation, blood type, direct antibody test, complete blood count, reticulocyte count, serum albumin, and G6PD screening in neonates with suspected cholestasis 7
Urine testing for reducing substances to evaluate for galactosemia is also recommended 7
Blood, urine, and cerebrospinal fluid cultures should be performed if sepsis is suspected 7

The American Academy of Pediatrics advises against subtracting direct bilirubin from total bilirubin when making treatment decisions about phototherapy or exchange transfusion 7
Phototherapy should be initiated despite the presence of direct hyperbilirubinemia if indicated by total bilirubin levels and standard nomograms for age and risk factors 7, 8
Phototherapy efficacy may be reduced in cholestasis, but some response typically occurs 8

Sepsis with cholestasis should be considered in the differential diagnosis of neonatal cholestasis 8
Congenital infections (TORCH) are also a potential cause of neonatal cholestasis 8